U3-1402, a Novel HER3-Targeting Antibody-Drug Conjugate, for the Treatment of Colorectal Cancer.
Koganemaru S, Kuboki Y, Koga Y, Kojima T, Yamauchi M, Maeda N, Kagari T, Hirotani K, Yasunaga M, Matsumura Y, Doi T.
Koganemaru S, et al. Among authors: yasunaga m.
Mol Cancer Ther. 2019 Nov;18(11):2043-2050. doi: 10.1158/1535-7163.MCT-19-0452. Epub 2019 Aug 8.
Mol Cancer Ther. 2019.
PMID: 31395690